Results
|
|
2061.
|
|
|
|
2062.
|
|
|
|
2063.
|
|
|
|
2064.
|
|
|
|
2065.
|
|
|
|
2066.
|
|
|
|
2067.
|
|
|
|
2068.
|
|
|
|
2069.
|
|
|
|
2070.
|
|
|
|
2071.
|
|
|
|
2072.
|
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy. [electronic resource] by
- Henriksen, Kim
- Byrjalsen, Inger
- Qvist, Per
- Beck-Nielsen, Henning
- Hansen, Gitte
- Riis, Bente J
- Perrild, Hans
- Svendsen, Ole Lander
- Gram, Jeppe
- Karsdal, Morten A
- Christiansen, Claus
Producer: 20110826
In:
Diabetes/metabolism research and reviews vol. 27
Availability: No items available.
|
|
|
2073.
|
|
|
|
2074.
|
|
|
|
2075.
|
|
|
|
2076.
|
|
|
|
2077.
|
|
|
|
2078.
|
|
|
|
2079.
|
|
|
|
2080.
|
|